Home Search Abstracts Browse Sessions Program Committee E-mail Abstract Author View Session


Session 115 Poster Abstracts
Risk Behavior
Tuesday, 1:30 - 3:30 pm
Poster Hall


845
High Risk Sexual Behavior in HIV-infected Adults with Genotypically Proven Antiretroviral Resistance
P V Chin-Hong*1, S Deeks1, T Liegler2, E Hagos1, M Krone1, R M Grant1,2, and J Martin1
1Univ. of California, San Francisco, USA and 2Gladstone Inst. of Virology and Immunology, San Francisco, CA, USA

Background:  The substantial frequency of drug resistance in persons recently infected with HIV implies exposure among HIV-uninfected individuals to HIV-infected persons with drug-resistant virus. While there is an increasing emphasis on understanding high-risk behavior among HIV-infected patients in general, little work has focused on those with drug-resistant virus.

Methods:  We examined HAART-treated patients in the Study of the Consequences of the Protease Inhibitor Era (SCOPE), a clinic-based cohort of HIV-infected adults. Sexual behavior was ascertained by self-administered questionnaire. Genotypic drug resistance testing was performed on patients with viral load >100 RNA copies/mL.

Results: Among 287 patients on HAART, 177 had viral load >100 copies/mL; 168 (95%) of these had resistance to at least one drug. The prevalence of high-risk sexual behavior in the prior 4 months in the drug-resistant viremia group was comparable to those with either viral load <100 copies/mL or with >100 copies/mL with wild type viremia (see the table). In a multivariable logistic model of predictors of unprotected anal or vaginal sex with a HIV-uninfected or status unknown partner, among the 168 patients with drug-resistant viremia there was strong evidence for an effect of age £35 (OR 8.8, p <0.01), depression (OR 3.4, p <0.05), and sildenafil use (OR 5.4, p <0.01), moderate evidence for lower education (OR 9.2, p = 0.09), alcohol use (OR 4.3, p = 0.12) and use of poppers, ecstasy, metamphetamines, or GHB (OR 2.9, p = 0.06) but no evidence for sexual orientation or adherence (p > 0.15).

 

 

 

Drug-resistant Viremia

Undetectable Viral Load or Wild Type Viremia

p

Homosexual men

n = 133

%

n = 93

%

 

Any unprotected anal sex

36/133

27

29/93

31

0.50

Any unprotected anal sex with HIV-negative/unknown partner

23/133

17

12/93

13

0.37

Heterosexual men and women

n = 35

%

n = 26

%

 

Any unprotected vaginal or anal sex

6/35

17

6/26

23

0.56

Any unprotected vaginal or anal sex with HIV negative/unknown partner

2/35

6

4/26

15

0.21

 

Conclusions: Among HIV-infected patients with drug-resistant viremia, there is a substantial prevalence of high-risk sex with HIV-uninfected partners. This frequency of high-risk behavior is comparable with other treated patients (most of whom have undetectable viral load), suggesting that a potentially significant group of transmitters is not being systematically identified for direct intervention. The presence of definable risk factors for unsafe sex suggests a role for targeted rather than broad intervention, particularly when resources are limited.

Keywords: Sex Behavior; Drug Resistance; Risk-Taking